Question: is this a 2) strong advice, 1) weak advice 0) no advice?

Pertuzumab significantly improved the rates of invasive-disease-free survival among patients with HER2-positive, operable breast cancer when it was added to trastuzumab and chemotherapy.
user
This is no advice
assistant